Introduction In April 2020 we shared a conversation with Professor Gerry Graham, Chair of Immunology at Glasgow University. This provided an insight into the scientific nature of the COVID-19 coronavirus in the context of pandemics, how the spread might evolve, and the potential government and scientific responses. With regards to treatment options, Professor Graham suggested […]
Investing beyond the virus The viral pandemic came from nowhere and will eventually be contained; it also seems likely that an effective vaccine will be ready by the end of the year (please see: Covid-19 A Dialogue, Edinburgh Partners). Economic life will start to pick up before then and in the short-term equity markets have […]
For financial markets, understanding the medical response is a precondition to understanding how the virus and the economic impact will unfold. To help us through these steps we have spent time with Professor Gerry Graham who is one of our expert advisors in the area of biological sciences.
Policymakers worldwide are tackling climate change through regulation and taxation. Typically, these policies have imposed costs on the users of carbon. An alternative approach is possible and in Europe the regulators will impose significant costs on the producers of cars rather than on drivers.
It has been over 60 years since James Watson and Francis Crick discovered the structure of DNA, the precious molecule that contains our genetic code, and a tremendous amount of progress has been made since then in our understanding of how our cells operate, communicate with each other, pass on traits to future generations, and even how they get sick.
